Definitions and Overview
Clinical Decision Rules (CDRs), also known as Decision “Instruments” or “Aids,” are evidence-based tools to assist the practitioner in decision-making for common complaints. In the Emergency Department (ED) setting, these decision aids are often used to help identify patients who might be at higher risk for serious conditions such as pulmonary embolism (PE) or intracranial hemorrhage (ICH), or they are used to prevent overuse of unnecessary testing, which is how many of the orthopedic rules are applied.
CDRs, despite being called “Rules,” are not meant to replace critical thinking from experienced practitioners. In fact, many CDRs have been directly compared against clinician gestalt or clinical practice, and they are not always better [1,2]. Additionally, some rules incorporate clinician gestalt, whereas the rule cannot even be applied unless the pre-test probability (based on the physician’s judgment of the likelihood of the disease) is below a pre-determined threshold [3]. Also, for a CDR to be useful to a practitioner, it must be practical. If a CDR is developed that has too many complicated variables, it is unlikely to be applied in a busy clinical environment [4].
Another caveat to the application of CDRs is that they must be applied appropriately. CDRs evolve through a process of derivation to validation to impact analysis of the tool. After the tool is derived (level 4 evidence), the tool is validated in a limited patient setting (level 3 evidence), then a broader validation setting (level 2 evidence), and finally, the impact of the tool is assessed (level 1 evidence) [5]. These levels are important to caution the novice learner against applying every CDR which has been derived and published automatically into their clinical practice. The tool must be validated in a patient population with similar characteristics to the practitioner’s patient population. For example, the tool may not perform the same (have the same sensitivity and specificity) if the prevalence of disease is different between the study and actual patient populations. Also, the practitioner must be familiar with a particular tool’s inclusion and exclusion criteria. If not, the tool could be misused. For example, if the tool was derived and validated for a patient population over the age of 18, it should not be inappropriately applied in a pediatric setting.
The practitioner must also understand the purpose of the CDR and whether it is a one-way or two-way rule. As noted by Green, for example, the Ottawa Ankle Rules are intended to be a two-way rule; if the patient meets the criteria, you do an X-ray; if they don’t meet the criteria, you do not do an X-ray [6]. There are two paths you can take after you apply your CDR. Alternatively, the pulmonary embolism rule-out criteria (PERC) demonstrate a one-way rule. This tool was developed to identify a subset of patients at very low risk for PE so that no further testing is needed. If the patient is “PERC positive,” this should not imply that further testing for PE, such as a D-dimer or CT angiogram of the chest, should be done. Whether or not additional testing should be done remains up to the practitioner and depends on many variables, including whether an alternate diagnosis is much more likely. PERC was designed to help “rule out” the diagnosis of PE, not “rule in.” This rule only guides you down one path: potentially, to do no testing; it makes no judgment as to what you should do if the patient is “PERC positive.”
In addition to CDRs, many risk stratification tools or scales have been used for serious conditions such as pulmonary embolism (PE) and acute coronary syndrome (ACS). Others have more recently been developed for use in the ED setting for common conditions such as congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), and transient ischemic attack (TIA) to identify patients at higher risk for acute severe complications [7]. From a practical perspective, the ED physician will often use these risk stratification devices to help determine which patients require admission. However, these tools are less prescriptive in that they are not rules that suggest what a practitioner should or should not do, but rather, they help the physician more objectively look at the risk for an individual patient. Then the practitioner must decide what level of risk they are comfortable with in regards to inpatient or outpatient management, which may greatly depend on the resources available in those environments. Most of the risk stratification tools encompass multiple variables with more complicated scoring systems; as they are not easily memorized, most of these would typically be used by ED physicians with real-time access to a computer or smartphone with appropriate apps.
Given the many pitfalls noted above of CDRs, the goals of using evidence-based medicine to reduce practice variability, maximize cost-effective use of resources, and help identify and diagnose high-risk conditions are important. It is equally important that the ED physician critically appraise these tools and selectively apply them in appropriate ways [8]. The remainder of this chapter will use case scenarios to review the most commonly used CDRs in the ED setting.
The useful FOAM reference MDCalc.com provides a summary of the most common tools that are being used with easy-to-use online calculators and additional information on inclusion and exclusion criteria, evidence basis for the tools, as well as pearls and pitfalls for each tool.
Orthopedic CDRs
Ottawa Knee, Ankle and Foot Rules
Case 1
A 28-year-old man presents to the ED with left ankle pain after twisting his ankle while playing basketball. He is able to bear weight and notes pain and swelling to the lateral aspect of the ankle (he points to just below the lateral malleolus). He denies weakness, numbness, or tingling and has no other injuries. On exam, he is neurovascularly intact. Edema and tenderness are noted slightly anterior and inferior to the lateral malleolus. There is no point tenderness to the distal posterior malleoli bilaterally.
Should you obtain an X-ray to check for a fracture?
Ottawa Ankle Rule
Pain in the malleolar zone and any one of the following:
- Bone tenderness along the distal 6 cm of the posterior edge or tip of the tibia (medial malleolus), OR
- Bone tenderness along the distal 6 cm of the posterior edge or tip of the fibula (lateral malleolus), OR
- An inability to bear weight immediately and in the emergency department for four steps.
Ottawa Foot Rule
Pain in the midfoot zone and any one of the following:
- Bone tenderness at the base of the fifth metatarsal, OR
- Bone tenderness at the navicular bone, OR
- An inability to bear weight immediately and in the emergency department for four steps.
Ottawa Knee Rule
Knee injury with any of the following:
- Age 55 years or older
- Tenderness at the head of the fibula
- Isolated tenderness of the patella
- Inability to flex to 90°
- Inability to bear weight both immediately and in the emergency department (4 steps)
The Ottawa knee, ankle, and foot rules are some of the longest-standing and most widely accepted CDRs. These rules help practitioners identify patients with an extremely low risk of fracture such that X-rays do not need to be done, thus limiting the risks and costs of unnecessary testing. The sensitivity of these rules has been found to be 98.5-100% [9-11]. In impact study of the Ottawa knee rule, application of the rule decreased the use of knee radiography without patient dissatisfaction or missed fractures and was associated with reduced waiting times and costs. These rules have also been validated in pediatric populations with similar sensitivities (98.5-100%) [12-14].
Case 1 Discussion
Base on the Ottawa ankle rule, an X-ray is unnecessary. The patient can be treated supportively for an ankle sprain. When it comes to treating an ankle sprain, supportive care is typically the most effective approach. This involves several key strategies aimed at reducing pain and promoting healing. First and foremost, it’s important to follow the R.I.C.E. method:
- Rest: Avoid putting weight on the injured ankle to prevent further damage. This might mean using crutches or a brace, especially in the initial days after the injury.
- Ice: Applying ice packs to the ankle for 15-20 minutes every couple of hours can help reduce swelling and numb the pain. It’s crucial to wrap the ice pack in a cloth to protect the skin.
- Compression: Using an elastic bandage or compression wrap around the ankle can help minimize swelling and provide support. It’s essential not to wrap it too tightly, as this could impede circulation.
- Elevation: Keeping the ankle raised above the level of the heart can also help reduce swelling and improve blood flow to the area, speeding up the healing process.
In addition to the R.I.C.E. method, over-the-counter pain relievers like ibuprofen or acetaminophen can be used to manage pain and inflammation. Gradually reintroducing movement and gentle stretching exercises can aid in restoring strength and flexibility, but this should be done cautiously and ideally under the guidance of a healthcare professional. Physical therapy may also be beneficial in some cases, especially if the sprain was severe or if there are concerns about stability in the ankle after healing. A physical therapist can provide tailored exercises and techniques to regain strength and prevent future injuries. Overall, the goal of supportive treatment for an ankle sprain is to promote recovery while alleviating pain, allowing the patient to return to their normal activities as safely and quickly as possible.
Trauma CDRs
Canadian Cervical Spine and NEXUS Rules
Case 2
A 57-year-old man fell from a height of 12 feet while on a ladder. He did not pass out; he reports losing his footing. He fell onto a grassy area, hitting his head, and complains of neck pain. He did not lose consciousness and denies headache, blurry vision, vomiting, weakness, numbness or tingling in any extremities. He denies other injuries. He was able to get up and ambulate after the fall and came in by private vehicle. He has not had previous spine surgery and does not have known vertebral disease. On exam, he is neurologically intact with a GCS of 15, does not appear intoxicated, and has moderate midline cervical spine tenderness.
Should you obtain imaging to rule out a cervical spine fracture?
Canadian C-spine Rule
- Age ≥ 65
- Extremity paresthesias
- Dangerous mechanism (fall from ≥ 3ft / 5 stairs, axial load injury, high-speed MVC/rollover/ejection, bicycle collision, motorized recreational vehicle)
NEXUS Criteria for C-spine Imaging
- Focal neurologic deficit
- Midline spinal tenderness
- Altered level of consciousness
- Intoxication
- Distracting injury
Case 2 Discussion
Applying either criteria to this case would require C-spine imaging, as by CCR, the patient would meet the criteria for dangerous mechanism, and by NEXUS, the patient has midline tenderness to palpation.
Canadian CT Head Rule and NEXUS Head CT Instrument
Case 3
A 36-year-old woman slipped on ice and fell and hit her head. She reports loss of consciousness for a minute after the event, witnessed by a bystander. She denies having headaches. She denies weakness, numbness, or tingling in her extremities and no changes in vision or speech. She has not vomited. She remembers the event except for the transient loss of consciousness. She doesn’t use any blood thinners or have any known coagulopathy. On physical exam, she has a GCS of 15, no palpable skull fracture or scalp hematoma, no signs of a basilar skull fracture, normal mentation, and no neurologic deficits.
Should you obtain a CT head for this patient to rule out a clinically significant brain injury?
Canadian CT Head Rule
High Risk Criteria (rules out need for neurosurgical intervention)
- GCS < 15 at two hours post-injury
- Suspected open or depressed skull fracture
- Any sign of basilar skull fracture (hemotypanum, Raccoon eyes, Battle’s sign, CSF oto or rhinorrhea)
Medium Risk Criteria (rules out clinically important brain injury)
- Retrograde amnesia to event ≥ 30 minutes
- Dangerous mechanism (pedestrian struck by motor vehicle, ejection from motor vehicle, fall from > 3 feet or > 5 stairs)
NEXUS Head CT Instrument
- Evidence of significant skull fracture
- Scalp hematoma
- Neurologic deficit
- Altered level of alertness
- Abnormal behavior
- Coagulopathy
- Persistent vomiting
- Age ≥65 years
The Canadian CT Head Rule (CCHR) only applies to patients with an initial GCS of 13-15, witnessed loss of consciousness (LOC), amnesia to the head injury event, or confusion [18]. The study was only for patients > 16 years of age. Patients were excluded from the study if they had “minor head injuries” that didn’t even meet these criteria. Patients were also excluded if they had signs or symptoms of moderate or severe head injury, including GCS < 13, post-traumatic seizure, focal neurologic deficits, or coagulopathy. The CCHR was designed to identify clinically important injuries and injuries requiring neurosurgical intervention. A potential limitation of its use could be if one works in a practice environment where the standard of care is to identify all intracranial injuries versus only those that require acute intervention.
The NEXUS Head CT Instrument was developed and validated more recently to address some of the limitations of rules, including the CCHR, where the inclusion and exclusion criteria may preclude its application in over one-third of blunt head injury cases, as well as other rules that focused only on pediatric populations such as PECARN [19-22]. The NEXUS Instrument is a one-way decision instrument for patients of all ages to identify low-risk patients who do not require CT imaging. The developers of the tool acknowledge that although its sensitivity is 100%, it is no better than the equal 100% sensitivity of clinical judgment [23]. Therefore, the benefit of its use is limited to “ruling out” significant intracranial injuries and reducing unnecessary testing. The developers also highlight that the use of CT imaging provides little information on concussions and post-concussive syndromes and that negative imaging does not preclude concussive injuries that can result in long-term brain injury and impairment.
Case 3 Discussion
By applying both rules to the above case, the patient does not require imaging despite her transient loss of consciousness after the injury.
PECARN Pediatric Head Trauma Algorithm
Case 4
A 20-month-old female was going up some wooden stairs, slipped and fell down four stairs, and hit the back of her head on the wooden landing at the bottom of the stairs. She did not lose consciousness and cried immediately. According to her parents, she was consolable after a few minutes and acted normally. She has not vomited. On exam, she is well-appearing, alert, and has a normal neurologic exam. She is noted to have a left parietal hematoma measuring approximately 4×4 cm.
Should you obtain CT imaging of this child to rule out clinically significant head injury?
PECARN Pediatric Head Trauma Algorithm
Age < 2
- GCS < 15, palpable skull fracture, or signs of altered mental status
- Occipital, parietal or temporal scalp hematoma; History of LOC≥5 sec; Not acting normally per parent or Severe Mechanism of Injury?
Age ≥ 2
- GCS < 15, palpable skull fracture, or signs of altered mental status
- History of LOC or history of vomiting or Severe headache or Severe Mechanism of Injury?
The PECARN (Pediatric Emergency Care Applied Research Network) Pediatric Head Trauma Algorithm was developed as a CDR to minimize unnecessary radiation exposure to young children. The estimated risk of lethal malignancy from a single head CT in a 1-year-old is 1 in 1000-1500 and decreases to 1 in 5000 in a 10-year-old [24]. Due to these risks, in addition to costs, length of stay and potential risks of procedural sedation, this CDR is widely employed given the frequency of pediatric head trauma ED visits. This CDR uses a prediction tree to assess risk, and unlike some other risk stratification tools, the PECARN group provides recommendations based on their definitions of acceptable risk levels. In the less than 2-year-old group, the rule was found to be 100% sensitive, with sensitivities ranging from 96.8%-100% sensitive in the greater than 2-year-old group [25,26].
This algorithm does have some complexity and ambiguity. It requires the practitioner to know what were considered signs of altered mental status and what were considered severe mechanisms of injury. In addition, certain paths of the decision tree lead to intermediate risk zones. In these cases, the recommendation is “observation versus CT,” allowing the ED physician to base their decision to image or not on numerous contributory factors, including physician experience, multiple versus isolated findings, and parental preference, among others.
Other pediatric head trauma CDRs have been derived and validated; however, in comparison trials, PECARN performed better than the other CDRs [1]. Of note, in this study, physician practice (without using a specific CDR) performed as well as PECARN with only slightly lower specificity.
Case 4 Discussion
The patient falls into an intermediate risk zone of clinically important brain injury. However, a sub-analysis of patients less than two years old with isolated scalp hematomas suggests that patients were at higher risk if they were < 3 months of age, had non-frontal scalp hematomas, large scalp hematomas (> 3cm), and had severe mechanism of injury [27]. Given the large hematoma in the case study patient and a severe mechanism of injury (a fall of > 3 feet in the under 2 yo age group), one should consider imaging due to these two additional higher risk factors.
PECARN Abdominal Trauma
- Evidence of abdominal wall trauma/seatbelt sign or GCS < 14 with blunt abdominal trauma (if no, go to next point) – 5.4% risk of needing intra-abdominal injury intervention
- Abdominal tenderness (if no, go to next point) – 1.4 % risk of intra-abdominal injury intervention
- Thoracic wall trauma, complaints of abdominal pain, decreased breath sounds, vomiting – 0.7% risk of intra-abdominal injury intervention
The PECARN group has also developed a CDR, which was externally validated for pediatric blunt abdominal trauma [28,29]. This CDR uses a seven-point decision rule. If the patient does not have any of these findings, the patient would be considered “very low risk,” with a 0.1% risk of intra-abdominal injury intervention required. A study compared the PECARN CDR versus clinical suspicion and found that the CDR had significantly higher sensitivity (97.0% vs. 82.8% but lower specificity (42.5% vs. 78.7%) [30]. However, abdominal CTs were done in 33% of patients with clinical suspicion < 1%, meaning that even though clinical suspicion had higher specificity, this often did not translate into clinical practice. A recent external validation study supported the use of the CDR in decreasing CT use in pediatric patients at very low risk for clinically important intra-abdominal injuries [29].
NEXUS Chest Decision Instrument for Blunt Chest Trauma
NEXUS Chest was derived and validated for blunt chest trauma patients to identify very low-risk patients that do not require imaging [31,32]. It was developed only to rule out injury, not ruling it in. In other words, finding one or more NEXUS Chest criteria does not mean you must image that patient. The CDR creators suggest using NEXUS Chest only in patients for whom imaging was planned, then apply NEXUS Chest to determine whether one can safely forego imaging.
Pulmonary CDRs
Case 5
A 19-year-old female presents with sharp right flank pain and shortness of breath, which started suddenly the day before arrival. The pain is worse with deep inspiration but not related to exertion and not relieved with ibuprofen. She denies anterior chest pain, cough, and fever. She denies leg pain or swelling and recent travel, immobilization, trauma, or surgery. She has no anterior abdominal pain, no dysuria or hematuria, and no personal or family history of gallstones, kidney stones, or blood clots. She’s never had this pain before, has no significant past medical history, and her only medication is birth control pills. On exam, her vital signs are within normal range; she has normal cardiac and pulmonary exams, no costo-vertebral angle tenderness, no chest wall or abdominal tenderness, and no leg swelling.
Do you need to do any studies to evaluate this patient for a pulmonary embolism?
Pulmonary Embolism Rule-Out Criteria (PERC)
- Age ≥ 50
- Heart rate ≥ 100
- O2 sat on room air < 95%
- Prior history of venous thromboembolism
- Trauma or surgery within 4 weeks
- Hemoptysis
- Exogenous estrogen
- Unilateral leg swelling
The PERC CDR was originally derived and validated in 2004 and with a subsequent multi-study center validation in 2008 [33,34]. In the larger validation study, the rule was only applied in those patients with a pre-test probability of < 15%, therefore incorporating clinical gestalt before using the rule. As mentioned above, PERC is a one-way rule that tries to identify patients with low risk for pulmonary embolism (PE) so as not to require any testing. It does not imply that testing should be done for patients who do not meet criteria, and it is not meant for risk stratification, as opposed to the Wells and Geneva scores.
Case 5 Discussion
To apply the PERC CDR to the case, the ED physician pre-supposes a pre-test probability of < 15%. If the ED physician has a higher pre-test probability than that, the physician should not use the PERC CDR. If the ED physician in this case did indeed have a pre-test probability of < 15%, the case study patient would fail the rule-out due to her use of oral contraceptives. In that case, the ED physician would need to determine if he/she would do further testing, which could include a D-dimer, CT chest with contrast, ventilation/perfusion scan, or lower extremity Doppler studies to evaluate for deep vein thromboses (DVTs). The PERC CDR gives no guidance in this case.
Wells and Revised Geneva Score for Pulmonary Embolism (PE)
Wells’ Criteria for Pulmonary Embolism | Point Value |
Clinical signs and symptoms of DVT | +3 |
PE is #1 diagnosis, or equally likely | +3 |
Heart rate > 100 | +1.5 |
Immobilization at least 3 days, or Surgery in the Previous 4 weeks | +1.5 |
Previous, objectively diagnosed PE or DVT | +1.5 |
Hemoptysis | +1 |
Malignancy w/ Treatment within 6 mo, or palliative | +1 |
Geneva Score (Revised) for Pulmonary Embolism | Point Value | |
Risk factors | Age > 65 | +1 |
| Previous DVT or PE | +3 |
| Surgery (under general anesthesia) or lower limb fracture in past 1 month | +2 |
| Active malignant condition | +2 |
Symptoms | Unilateral lower limb pain | +3 |
| Hemoptysis | +2 |
Signs | Heart rate < 75 | 0 |
| Heart rate 75 – 94 | +3 |
| Heart rate ≥ 95 | +5 |
| Pain on lower limb deep venous palpation and unilateral edema | +4 |
The Wells’ Criteria for PE is a risk stratification score with different point values assigned to different criterion. Its purpose is to identify patients with a lower PE risk to avoid unnecessary testing and the associated risks and costs [35]. The criteria have been validated in the ED setting [36]. The initial study used a three-tier model to classify patients as low, medium, or high risk. Subsequent studies have been done to apply a simplified version of the Wells’ Criteria and also to use the Wells’ Criteria along with D-dimer testing in a dichotomous manner (two-tier model) where a score of 4 or less (“PE Unlikely” group) combined with a negative D-dimer would achieve sufficiently low probability of PE so as not to pursue further work-up [37-39]. This two-tier model is supported by the American College of Physicians (ACEP) Clinical Guidelines [40]. A two-tier model using a cut-off of less than 6 for low-risk was also studied in pregnant patients with a negative predictive value of 100% [41].
The original Geneva score included chest radiography and an ABG, whereas the revised score (rGeneva) uses only clinical criteria [42]. A patient with an rGeneva score of 0-3 is considered low risk with a < 10% prevalence of PE. A score of 4-10 identifies intermediate-risk patients, and a score of 11+ is high risk (>60% prevalence or PE).
The Wells and rGeneva scores have been compared and found to have overall similar accuracy [43-45]. These PE risk stratification tools are meant to be applied to patients with concern for PE as a diagnosis. If PE is not under consideration, the tools should not be applied. Practically speaking, for many ED physicians, these tools are used to help risk stratify patients to identify those who are very low-risk such that no testing should be done, low to intermediate risk such that D-dimer testing would be a useful diagnostic tool, or high risk such that even if a D-dimer were negative, the post-test probability would remain high enough that further testing should be pursued. One recent study found that physician gestalt performed better than the Wells or rGeneva scores [45]. However, guidelines from the Clinical Practice Committee of the American College of Physicians (ACP) were published in 2015 that outline best practice advice including advocating that clinicians should use validated CDRs to estimate pre-test probability in patients in whom acute PE is being considered [46].
YEARS Algorithm for Pulmonary Embolism
The YEARS Algorithm was derived in 2017 and subsequently validated in studies in 2018 and 2021 [47-49]. It consists of the three most predictive criteria of the Well’s Score for PE and incorporates variable D-dimer thresholds, depending on the number of criteria fulfilled. It has the benefit of reducing the use of CT Pulmonary Angiogram by more broadly utilizing the results of D-dimer testing for selected patients. Additionally, a pregnancy-adapted algorithm was developed in 2019, which may be useful for clinicians struggling with the challenge of excluding PE in this sub-group, which has both a higher risk of PE and of radiation exposure to the fetus of performing the “gold standard” test which is considered a CT angiogram [50]. A recent study found that using the YEARS algorithm in combination with an age-adjusted D-dimer strategy was non-inferior to conventional diagnostic strategies and decreased chest imaging by 14% [51].
Pneumonia Severity Index (PSI) Score
The PSI Score estimates mortality for adult patients with community-acquired pneumonia (CAP). It is recommended as a Clinical Practice Guideline by the American Thoracic Society and Infectious Disease Society to use the PSI, in addition to clinical judgment, to determine the need for hospitalization in patients with CAP [52]. Although it has more variables than the CURB-65 Score, it was found to identify larger proportions of patients as low risk and found to have better discriminative power in predicting mortality. It includes variables such as age and sex as well as vital signs, co-morbidities, lab values, and imaging findings, which may limit its use in some resource-limited settings.
Ottawa COPD Risk Scale
The Ottawa COPD Risk Scale predicts 30-day mortality or serious adverse events in ED patients with COPD [53]. It was developed and validated to assist with disposition decisions to avoid admitting low-risk patients suitable for discharge and to avoid discharging high-risk patients [54]. It incorporates elements of the patient’s medical history and exam in the ED as well as testing, including an EKG, chest X-ray, hemoglobin, urea, and CO2.
Cardiac CDRs
Case 6
A 50-year-old male presents to the ED complaining of chest pain for two days. His pain is substernal and non-radiating. He described it as a tightness and is not related to exertion. He has no associated shortness of breath, nausea, or diaphoresis. No cough or fever. He’s never had this pain before. He has a history of hypertension but no other cardiac risk factors. His exam in the ED is normal, and his EKG and initial troponin are normal.
Does this patient require additional cardiac workup in the ED or admission to the hospital for further workup? Can this patient be safely discharged for outpatient follow-up?
HEART Score for Cardiac Events
HEART Score |
| Points |
History | Highly suspicious | +2 |
| Moderately suspicious | +1 |
| Slightly suspicious | 0 |
EKG | Significant ST depression | +2 |
| Non specific repolarization disturbance | +1 |
| Normal | 0 |
Age | ≥ 65 | +2 |
| 45-65 | +1 |
| ≤ 45 | 0 |
Risk Factors (include: hypercholesterolemia, hypertension, diabetes mellitus, cigarette smoking, positive family history, obesity) | ≥ 3 risk factors or history of atherosclerotic disease | +2 |
| 1-2 risk factors | +1 |
| No risk factors known | 0 |
Troponin | ≥ 3× normal limit | +2 |
| 1-3× normal limit | +1 |
| ≤ normal limit | 0 |
The HEART Score is used to risk stratify chest pain patients in the ED to identify those at risk for major adverse cardiac events (MACE) within six weeks [55]. In the HEART Score, patients with a low risk (score between 0 and 3) indicate a less than 2% risk of major adverse cardiovascular events (MACE) within six weeks. The HEART Score differs from the Thrombolysis in Myocardial Infarction (TIMI) and Global Registry of Acute Coronary Events (GRACE) scores as those scores measure the risk of death for patients with diagnosed acute coronary syndromes (ACS) rather than identifying patients who have cardiac-related chest pain in the first place [56,57]. Additionally, even with low TIMI scores for those diagnosed with ACS in the ED, there is still a 4.7% risk of a bad outcome [56]. This may be of little utility to the ED physician, who finds this risk level unacceptable.
Case 6 Discussion
This patient’s HEART Score is 3 if the physician considers the history “moderately suspicious.” The patient is at low risk for a major cardiac event in the next six weeks so that the ED physician could consider outpatient follow-up. Again, the risk stratification scores are not prescriptive, however. The clinician must make decisions based on his/her judgment, available resources, and comfort with certain levels of risk.
Emergency Department Assessment of Chest Pain Score (EDACS)
Similar to the HEART Score, the EDACS is used to further risk stratify patients with chest pain or other anginal symptoms requiring evaluation for possible acute coronary syndrome who may be potentially low risk and appropriate for early discharge from the emergency department [58]. It should only be applied in patients without ongoing chest pain. The score was 99-100% sensitive in the original derivation paper, and some studies showed it to be more sensitive than the HEART score and better at identifying more low-risk patients [59,60]. That said, a more recent meta-analysis reported a pooled sensitivity of only 96.1%, which may not be considered adequately sensitive by some providers or in some practice environments [61].
Ottawa Heart Failure Risk Score
The Ottawa Heart Failure Risk Scale (OHFRS) was derived in 2013 and validated in 2017 in Canada [62, 63]. It identifies ED patients with heart failure (HF) at high risk for serious adverse events, including death, MI, and the need for ICU/intubation. It is to be used for ED patients presenting with HF exacerbation who have responded to treatment in the ED to help clinicians determine whether admission might be warranted versus discharge for low-risk patients. The study authors looked at the performance of the CDR both with and without a Quantitative NT-proBNP diagnostic test. They found the CDR was valuable even without the availability of this test, which might improve its usefulness in different resource settings. That said, regional practice patterns should be considered when applying this score, such as differences overall in heart failure admission rates.
Atrial Fibrillation – the CHA2DS2-VASc and HAS-BLED Scores
The main clinical decision instruments regarding atrial fibrillation (afib) relate to whether or not to anticoagulate a patient in afib, weighing the risk of stroke without anticoagulation versus the risk of a major bleeding event. The CHA2DS2-VASc Score was developed in an era where Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) are available in higher-resource settings, in addition to traditional warfarin, and in light of more recent evidence regarding the lack of efficacy and safety of aspirin for stroke prevention in afib [64,65]. The score is simple to use with variables of age, sex, and the patient’s medical history. The European Society of Cardiology guidelines recommend using the score to identify truly low-risk patients (0 for males or 1 for females) who do not need anticoagulation therapy [66]. The American Heart Association and American College of Cardiology guidelines also endorse using the CHA2DS2-VASc score as the stroke risk assessment tool of choice [67].
In addition to considering the risk of stroke in patients with afib, however, one also has to consider the risk of bleeding due to taking anticoagulants. Unfortunately, many risk factors for the former are also risk factors for the latter. The score that performs best for identifying the risk of bleeding is the HAS-BLED score [68-70]. The HAS-BLED authors note that while it does not identify absolute cut-offs for when not to use anticoagulants, it does help identify some risk factors that could be avoided or reversed, for example, by controlling hypertension or avoiding alcohol use or other medications that may predispose to bleeding. The decision of whether or not to anticoagulated a patient in afib is complex, but these CDRs provide some objective assessment of risk to inform decision-making and educate patients, and include them in shared-decision making.
Abdominal CDRs
Gastrointestinal Bleeding
Case 7
A 30-year-old male presents to the ED with nausea, vomiting, and epigastric discomfort for one day. He vomited multiple times, initially non-bloody, then developed some blood in the vomit during the last two episodes, which he quantified as a teaspoon in each. He denies melena or hematochezia. He has no diarrhea, fever, or syncope. He denies a history of liver or heart problems. On exam, he has normal vital signs with an initial blood pressure of 128/78 mmHg in the ED, and his abdomen is non-tender. His hemoglobin is 13.5, and his BUN is 5.
Does this patient need admission for further monitoring or evaluation of his upper GI bleed?
Glasgow-Blatchford Bleeding Score (GBS)
- Hemoglobin < 13 for men or < 12 for women
- BUN > 6.5
- Initial systolic blood pressure < 110
- Heart rate ≥ 100
- Melena present
- Recent syncope
- Hepatic disease history
- Cardiac failure
The Glasgow-Blatchford Bleeding Score (GBS) uses clinical information and some diagnostic testing to risk stratify upper GI bleeding patients[71,72]. It should not be used for lower GI bleeding patients or patients in whom the source of GI bleeding is unclear. A score of 0 is considered low risk. Any score higher than 0 is considered high risk for needing a medical intervention of transfusion, endoscopy, or surgery; therefore, any of the above criteria would be considered high risk. The tool assigns different point values to different gradations of the variables present to a possible highest possible score of 29. The GBS has performed better than other CDRs in predicting patients likely to need hospital-based intervention or are at risk for mortality [73].
Case 7 Discussion
The patient does not meet any of the GBS criteria and would be considered low-risk. Based on this risk stratification, the patient does not demonstrate any signs of lower GI bleeding and could likely be safely discharged home.
Oakland Score for Safe Discharge After Lower GI Bleed
Similar to the GBS Score, the Oakland Score helps identify low-risk patients with lower GI bleeding who are candidates for outpatient management. It is simple to use in most settings and includes age, sex, history, physical exam findings in the ED, and hemoglobin level [74,75].
Appendicitis - Alvarado Score and Pediatric Appendicitis Risk Calculator (pARC)
The Alvarado Score was developed to predict the likelihood of acute appendicitis in patients with abdominal pain [76]. It utilizes a combination of signs, symptoms, and a WBC count with differential to create a risk score. The score is best utilized to avoid unnecessary CT imaging in very low-risk patients or even potentially in very high-risk patients, particularly in low-resource settings where CT is not commonly available [77]. In a study comparing the Alvarado Score with another CDR for pediatric appendicitis, the Pediatric Appendicitis Score, the gestalt of a pediatric surgeon was found to be higher than either scoring system; however, the Alvarado Score may be useful in emergency settings without experienced clinicians [78].
The pARC was also developed specifically for pediatric patients aged 5-18 to identify risk for acute appendicitis [79]. It may be used to help determine the need for advanced imaging and identify low-risk patients who could be observed or discharged from the ED with follow-up or return precautions. The Alvarado Score relies on signs, symptoms, and the availability of WBC and neutrophil counts. In its validation study, it performed better than the Pediatric Appendicitis Score [80].
STONE Score for Uncomplicated Ureteral Stone
The STONE Score was developed to identify patients with a high likelihood of uncomplicated ureterolithiasis who could be managed empirically, minimizing the use of CT or possibly using a low radiation CT protocol [81-83]. It has simple demographic and symptom-based variables with the addition of a urine dipstick; it is, therefore, easy to apply across resource settings. A high STONE Score can decrease the likelihood of an alternative diagnosis to < 2%, potentially limiting unnecessary costs and radiation exposure associated with CT imaging. Ultrasound demonstrating hydronephrosis, in addition to the score, can further increase the likelihood of a stone [84]. Given the increased availability and use of point-of-care ultrasound (POCUS) in emergency settings, using the STONE score in combination with ultrasound is a prudent approach to avoid CT use. A caveat to the STONE score is that it should not be used in ill-appearing patients or those with signs or symptoms suggestive of a possible complicated ureterolithiasis, for example, if there is evidence of a concomitant infection.
Neurologic CDRs
Case 8
A 24-year-old woman presents with a headache that began three hours before arrival at the ED. The patient was at rest when the headache started. The headache was not described as a “thunderclap,” but it did reach maximum severity within the first 30 minutes. The headache is generalized and rated 10/10. She denies head trauma, weakness, numbness, and tingling in her extremities. She denies visual changes, changes in speech, and neck pain. She has not taken anything for the headache. She does not have a family history of cerebral aneurysms or polycystic kidney disease. She had a normal neurologic exam and normal neck flexion during the physical exam.
Should you do a head CT and/or a lumbar puncture to evaluate for a sub-arachnoid hemorrhage in this patient?
Ottawa SAH Rule
Investigate if ≥1 high-risk variable is present:
- Age ≥ 40
- Neck pain or stiffness
- Witnessed loss of consciousness
- Onset during exertion
- Thunderclap headache (instantly peaking pain)
- Limited neck flexion on exam
A CDR to determine the risk for subarachnoid hemorrhage (SAH) was derived and externally validated in a single study [85,86]. The purpose of the CDR was to identify individuals at high risk for SAH. This included those experiencing acute non-traumatic headaches that reached maximal intensity within one hour and had normal neurological examinations. Notably, the rule consists of several criteria for inclusion and exclusion, which the emergency department physician must understand. Additionally, it was derived only for patients aged 16 years and older. The study authors note that the CDR is to identify patients with SAH; it is not an acute headache rule. In the validation study, of over 5000 ED visits with acute headaches, only 9% of those met the inclusion criteria [86]. Additionally, clinical gestalt plays a significant role as the authors recommend not applying the CDR to individuals who are at ultra-high risk with a pre-test probability of SAH greater than 50%.
The Ottawa SAH Rule was 100% sensitive but did not reduce testing compared to current practice [85]. The authors state that the rule’s value would be standardizing physician practice and avoiding the relatively high rate of missed sub-arachnoid hemorrhages.
Case 8 Discussion
By applying the Ottawa SAH Rule, this patient is low risk and does not require further investigation for a SAH.
Canadian Transient Ischemic Attack (TIA) Score
The Canadian TIA Score was developed to identify patients at high risk for stroke in the next seven days after a TIA [87,88]. It is calculated based on clinical findings and ED testing, including an EKG, CT, platelet count, and glucose. The validation study also looked at the outcome of carotid endarterectomy or carotid artery stenting within seven days and found that the Canadian TIA Score outperformed the ABCD2 risk stratification tool. It is unclear yet how the application of the tool will impact ED practice, which will likely depend on many factors, including inpatient versus outpatient access to resources. The validation study authors suggest, “The optimal management pathway at the local or regional level can be determined on the basis of the expected risk at a given risk category (for example, same day computed tomography with routine follow-up for patients at low risk, computed tomography angiography and rapid follow-up for those at medium risk, and neurology consultation in the emergency department for those at high risk) [88].”
Other CDRs
San Francisco Syncope Rule
The San Francisco Syncope Rule uses five factors to identify patients who are at high risk of serious outcomes at seven days, including a history of congestive heart failure, hematocrit < 30%, abnormal EKG, shortness of breath, and systolic BP < 90mmHg at triage. In its initial derivation and validation studies, it was found to have 92% and 98% sensitivity, respectively [89, 90]. Its use is controversial, however, due to inconsistent validation studies where it has not performed as well [91,92]. A systematic review of the literature from 2011 suggested that “the probability of a serious outcome given a negative score with the San Francisco Syncope Rule was 5% or lower, and the probability was 2% or lower when the rule was applied only to patients for whom no cause of syncope was identified after initial evaluation in the emergency department [93].” Although there is no consensus on using this tool to safely discharge patients with syncope home if they do not meet these criteria, patients with criteria would be considered a higher risk, possibly warranting observation, admission, and/or further diagnostic studies.
Centor Score for Streptococcal Pharyngitis
The Centor Score is a risk stratification tool that looks at clinical criteria that suggest a greater likelihood of strep pharyngitis, which may prompt the ED physician to prescribe antibiotics [94]. It was initially designed for use in adults. However, a modified score has been validated for use in children > 2 years of age and adults that includes age criteria, as strep pharyngitis is a more common condition in children [95,96]. With a score of 4 or more points, the probability of strep is greater than 50%, and some would advocate for empiric antibiotics in this group to reduce suppurative (peritonsillar abscess, cervical lymphadenitis, and mastoiditis) and non-suppurative (e.g., acute rheumatic fever) complications of strep pharyngitis and shorten the duration of clinical symptoms and as well as to reduce transmission [97]. Rapid antigen detection tests have been found to have a sensitivity of between 70 and 90% and a specificity of ≥95% [97]. Some authors recommend rapid antigen detection testing (RADT) only for children with high clinical scores or if the results of the standard throat culture will not be available for more than 48 hours [97,98]. Studies have found that tonsillar exudates conferred the highest odds of strep infection [96,99].
Conclusion
Clinical Decision Rules (CDRs) or Instruments are increasingly being used to assist ED clinicians in navigating complex decision-making regarding diagnostic testing, clinical care, and disposition determination of emergency patients. These tools have the potential to supplement clinician gestalt, maximize the use of limited and expensive resources (e.g., inpatient beds, CTs), and minimize the use of possibly unnecessary costly or dangerous testing or treatments (e.g., CTs, anticoagulants).
While CDRs are a valuable adjunct to the emergency clinician, ED providers must carefully apply these based on validation cohorts representative of the clinician’s patient population and carefully consider the inclusion and exclusion criteria in the studies. CDRs should not supplant physician critical decision-making based on individualized patient-centered factors and circumstances including resources available, ability to establish outpatient follow-up, and shared-decision making with informed patients. CDRs may be particularly valuable for less experienced clinicians who are learning to identify patient characteristics, symptoms, physical exam findings, risk factors and testing that will help them diagnose and manage complex emergency patients in variable practice environments.
Author
Stacey Chamberlain
Dr. Stacey Chamberlain is a board certified emergency physician who is a Professor in the Department of Emergency Medicine at the University of Illinois at Chicago (UIC). She also serves as the Director of the Global Emergency Medicine Fellowship Program and the Co-Director of the Social Emergency Medicine Fellowship Program. In addition to her work in Emergency Medicine, she is the Director of Academic Programs at the UIC Center for Global Health. In this role, she oversees the Global Medicine (GMED) Program for UIC medical students and the graduate global health certificate programs. Dr. Chamberlain has done clinical, educational, public-health, disaster-response, and emergency medicine development work, including working with several globally-focused NGOs, spanning five continents. Her global health work focuses on capacity building in emergency care in Uganda.
Listen to the chapter
2018 version of this topic – https://iem-student.org/clinical-decision-rules/
References
- Easter JS, Bakes K, Dhaliwal J, Miller M, Caruso E, Haukoos JS. Comparison of PECARN, CATCH, and CHALICE rules for children with minor head injury: a prospective cohort study. Ann Emerg Med. 2014 Aug; 64(2):145-52, 152.e1-5. doi: 10.1016/j.annemergmed.2014.01.030. Epub 2014 Mar 11.
- Lucassen W, Geersing GJ, Erkens PMG, Reitsma JB, Moons KGM, Büller H, van Weert HC. Clinical decision rules for excluding pulmonary embolism: a meta-analysis. Ann Intern Med. 2011 October 4; 155(7): 448–460. doi: 10.7326/0003-4819-155-7-201110040-00007
- Kline JA, Courtney DM, Kabrhel C, Moore CL, Smithline HA, Plewa MC, Richman PB, O’Neil BJ, Nordenholz K. Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. J Thromb Haemost. 2008 May; 6(5):772-80. doi: 10.1111/j.1538-7836.2008.02944.x. Epub 2008 Mar 3.
- Ferreira G, Carson JL. Clinical prediction rules for the diagnosis of pulmonary embolism. Am J Med. 2002; 113:337–338.
- Childs JD and Cleland Development and application of clinical prediction rules to improve decision making in physical therapist practice. Physical Therapy. 2006 January; 86(1):122-131.
- Green SM. When do clinical decision rules improve patient care? Annals of Emergency Medicine. 2014 March;63(3):373.
- Emergency Medicine Cases. Episode 56 The Stiell Sessions: Clinical Decision Rules and Risk Scales. Available online at: http://emergencymedicinecases.com/episode-56-stiell-sessions-clinical-decision-rules-risk-scales/. Accessed Dec 2, 2015.
- Green SM, Schriger DL, Yealy, DM. Methodologic standards for interpreting clinical decision rules in emergency medicine: 2014 Update. Annals of Emergency Medicine. 2014 Sept; 64(3): 286-291.
- Seaberg DC, Jackson R. Clinical decision rule for knee radiographs. Am J Emerg Med. 1994; 12: 541-543.
- Stiell IG, Wells GA, Hoag RH, Sivilotti ML, Cacciotti TF, Verbeek PR, Greenway KT, McDowell I, Cwinn AA, Greenberg GH, Nichol G, Michael JA. Implementation of the Ottawa knee rule for the use of radiography in acute knee injuries. JAMA.1997; 278: 2075-2079. http://dx.doi.org/10.1001/jama.278.23.2075
- Bachmann LM, Haberzeth S, Steurer J, ter Riet G. The accuracy of the Ottawa knee rule to rule out knee fractures: a systematic review. Ann Intern Med. 2004 Jan 20; 140(2): 121-4.
- Stiell IG, Wells GA, Hoag RH, et al. Implementation of the Ottawa Knee Rule for the use of radiography in acute knee injuries. 1997; 278(23): 2075-2079. doi:10.1001/jama.1997.03550230051036.
- Bulloch B, Neto G, Plint A, Lim R, Lidman P, Reed M, Nijssen-Jordan C, Tenenbein M, Klassen TP, Bhargava R; Pediatric Emergency Researchers of Canada. Validation of the Ottawa Knee Rule in children: a multicenter study. Ann Emerg Med. 2003 Jul; 42(1): 48-55.
- Dowling S, Spooner CH, Liang Y, Dryden DM, Friesen C, Klassen TP, Wright RB. Accuracy of Ottawa Ankle Rules to exclude fractures of the ankle and midfoot in children: a meta-analysis. Acad Emerg Med. 2009 Apr; 16(4): 277-87. doi: 10.1111/j.1553-2712.2008.00333.x. Epub 2009 Feb 2.
- Hoffman JR, Wolfson AB, Todd K, Mower WR. Selective cervical spine radiography in blunt trauma: methodology of the National Emergency X-Radiography Utilization Study (NEXUS). Ann Emerg Med. 1998 Oct; 32(4): 461-9.
- Stiell IG, Wells GA, Vandemheen KL, Clement CM, Lesiuk H, De Maio VJ, Laupacis A, Schull M, McKnight RD, Verbeek R, Brison R, Cass D, Dreyer J, Eisenhauer MA, Greenberg GH, MacPhail I, Morrison L, Reardon M, Worthington J. The Canadian C-spine rule for radiography in alert and stable trauma patients. JAMA. 2001 Oct 17; 286(15): 1841-8. PubMed PMID: 11597285
- Stiell, IG, Clement CM, McKnight RD, Brison R, Schull MJ, et al. The Canadian C-spine rule versus the NEXUS low-risk criteria in patients with trauma. New England Journal of Medicine. 2003; 349(26): 2510-2518.
- Stiell, IG, Wells GA, Vandemheen K. et al, The Canadian CT Head Rule for patients with minor head injury. Lancet. 2001; 357: 1391–1396.
- Harnan SE, Pickering A, Pandor A, Goodacre SW. Clinical decision rules for adults with minor head injury: a systematic review. J Trauma. 2011 Jul; 71(1): 245-51. doi: 10.1097/TA.0b013e31820d090f.
- Bouida W, Marghli S, Souissi S, Ksibi H, Methammem M, et al. Prediction value of the Canadian CT head rule and the New Orleans criteria for positive head CT scan and acute neurosurgical procedures in minor head trauma: a multicenter external validation study. Ann Emerg Med. 2013 May;61(5):521-7. doi:10.1016/j.annemergmed.2012.07.016. Epub 2012 Aug 22.
- Mower WR, Hoffman JR, Herbert M, Wolfson AB, Pollack CV Jr, Zucker MI; NEXUS II Investigators. Developing a decision instrument to guide computed tomographic imaging of blunt head injury patients. J Trauma. 2005 Oct;59(4):954-9. doi: 10.1097/01.ta.0000187813.79047.42. PMID: 16374287.
- Mower WR, Gupta M, Rodriguez R, Hendey GW. Validation of the sensitivity of the National Emergency X-Radiography Utilization Study (NEXUS) Head computed tomographic (CT) decision instrument for selective imaging of blunt head injury patients: An observational study. PLoS Med. 2017 Jul 11;14(7):e1002313. doi: 10.1371/journal.pmed.1002313. PMID: 28700585; PMCID: PMC5507397.
- NEXUS CT Head Instrument. Creator Insights. Dr. William R. Mower. Accessed at https://www.mdcalc.com/calc/10423/nexus-head-ct-instrument#creator-insights on November 11, 2022.
- Brenner D, Elliston C, Hall E, Berdon W. Estimated risks of radiation-induced fatal cancer from pediatric CT. AJR Am J Roentgenol. 2001 Feb; 176(2): 289-96.
- Kuppermann N, Holmes JF, Dayan PS, Hoyle JD Jr, Atabaki SM, et al. Pediatric Emergency Care Applied Research Network (PECARN). Identification of children at very low risk of clinically-important brain injuries after head trauma: a prospective cohort study. Lancet. 2009 Oct 3; 374(9696): 1160-70. doi: 10.1016/S0140-6736(09)61558-0. Epub 2009 Sep 14. Erratum in: Lancet. 2014 Jan 25;383(9914):308.
- Schonfeld D, Bressan S, Da Dalt L, Henien MN, Winnett JA, Nigrovic LE. Pediatric Emergency Care Applied Research Network head injury clinical prediction rules are reliable in practice. Arch Dis Child. 2014 May; 99(5): 427-31. doi: 10.1136/archdischild-2013-305004. Epub 2014 Jan 15.
- Dayan PS, Holmes JF, Schutzman S et al. Risk of traumatic brain injuries in children younger than 24 months with isolated scalp hematomas. Ann Emerg Med. 2014; 64: 153–162.
- Holmes JF1, Lillis K, Monroe D, Borgialli D, Kerrey BT, Mahajan P, et al. Identifying children at very low risk of clinically important blunt abdominal injuries. Ann Emerg Med. 2013 Aug; 62(2): 107-116.e2. doi: 10.1016/j.annemergmed.2012.11.009. Epub 2013 Feb 1.
- Springer E, Frazier SB, Arnold DH, Vukovic AA. External validation of a clinical prediction rule for very low risk pediatric blunt abdominal trauma. Am J Emerg Med. 2019 Sep;37(9):1643-1648. doi: 10.1016/j.ajem.2018.11.031. Epub 2018 Nov 23. PMID: 30502218.
- Mahajan P, Kuppermann N, Tunik M, Yen K, Atabaki SM, et al. Comparison of clinician suspicion versus a clinical prediction rule in identifying children at risk for intra-abdominal injuries after blunt torso trauma. Acad Emerg Med. 2015 Sep; 22(9): 1034-41. doi: 10.1111/acem.12739. Epub 2015 Aug 20.
- Rodriguez RM, Hendey GW, Mower W, Kea B, Fortman J, Merchant G, Hoffman JR. Derivation of a decision instrument for selective chest radiography in blunt trauma. J Trauma. 2011 Sep;71(3):549-53. doi: 10.1097/TA.0b013e3181f2ac9d. PMID: 21045745.
- Rodriguez RM, Anglin D, Langdorf MI, Baumann BM, Hendey GW, Bradley RN, Medak AJ, Raja AS, Juhn P, Fortman J, Mulkerin W, Mower WR. NEXUS chest: validation of a decision instrument for selective chest imaging in blunt trauma. JAMA Surg. 2013 Oct;148(10):940-6. doi: 10.1001/jamasurg.2013.2757. Erratum in: JAMA Surg. 2013 Dec;148(12):1086. PMID: 23925583.
- Kline JA, Mitchell AM, Kabrhel C, et al. Clinical criteria to prevent unnecessary diagnostic testing in emergency department patients with suspected pulmonary embolism. J Thromb Haemost. 2004; 2: 1247-1255.
- Kline JA, et al. Prospective multicenter evaluation of the pulmonary embolism rule-out criteria. J Thromb Haemost 2008; 6: 772–80. (PMID: 18318689).
- Wells PS, Anderson DR, Rodger M, Stiell I, Dreyer JF, Barnes D, Forgie M, Kovacs G, Ward J, Kovacs MJ. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med. 2001 Jul 17; 135(2): 98-107. PubMed PMID: 11453709.
- Wolf SJ, McCubbin TR, Feldhaus KM, Faragher JP, Adcock DM. Prospective validation of Wells Criteria in the evaluation of patients with suspected pulmonary embolism. Ann Emerg Med. 2004 Nov; 44(5): 503-10. PubMed PMID: 15520710.
- Douma RA, Gibson NS, Gerdes VEA, Büller HR, et al. Validity and clinical utility of the simplified Wells rule for assessing clinical probability for the exclusion of pulmonary embolism. Thromb Haemost. 2009; 101(1): 197-200 (ISSN: 0340-6245)
- Wells PS, Anderson DR, Rodger M, et. al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost. 2000 Mar; 83(3): 416-20.
- Writing Group for the Christopher Study Investigators. Effectiveness of Managing Suspected Pulmonary Embolism Using an Algorithm Combining Clinical Probability, D-Dimer Testing, and Computed Tomography. 2006; 295(2): 172-179. doi:10.1001/jama.295.2.172.
- American College of Emergency Physicians. Evaluation and Management of Adult Emergency Department Patients with Suspected Pulmonary Embolism (January 2011): Complete Clinical Policy on Suspected Pulmonary Embolism. Available online: http://www.acep.org/MobileArticle.aspx?id=80332&parentid. Accessed Dec 2, 2015.
- O’Connor C, Moriarty J, Walsh J, Murray J, Coulter-Smith S, Boyd W. The application of a clinical risk stratification score may reduce unnecessary investigations for pulmonary embolism in pregnancy. J Matern Fetal Neonatal Med. 2011 Dec.; 24(12): 1461-4.
- Le Gal G, Righini M, Roy PM, Sanchez O, Aujesky D, Bounameaux H, Perrier A. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med. 2006 Feb 7; 144(3): 165-71. PubMed PMID: 16461960.
- Klok FA, Kruisman E, Spaan J, Nijkeuter M, Righini M, et al. Comparison of the revised Geneva score with the Wells rule for assessing clinical probability of pulmonary embolism. J Thromb Haemost. 2008 Jan; 6(1): 40-4. Epub 2007 Oct 29.
- Ceriani E, Combescure C, Le Gal G, Nendaz M, Perneger T, et al. Clinical prediction rules for pulmonary embolism: a systematic review and meta-analysis. J Thromb Haemost. 2010 May; 8(5): 957-70. doi: 10.1111/j.1538-7836.2010.03801.x. Epub 2010 Feb 2.
- Penaloza A, Verschuren F, Meyer G, Quentin-Georget S, Soulie C, et al. Comparison of the unstructured clinician gestalt, the wells score, and the revised Geneva score to estimate pretest probability for suspected pulmonary embolism. Ann Emerg Med. 2013 Aug;62(2):117-124.e2. doi: 10.1016/j.annemergmed.2012.11.002. Epub 2013 Feb 21.
- Raja AS, Greenberg JO, Qaseem A, Denberg TD, Fitterman N, et al. Evaluation of Patients With Suspected Acute Pulmonary Embolism: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med. 2015 Nov 3; 163(9): 701-11. doi: 10.7326/M14-1772. Epub 2015 Sep 29.
- Van der Hulle T, Cheung WY, Kooij S, Beenen LFM, van Bemmel T, van Es J, Faber LM, Hazelaar GM, Heringhaus C, Hofstee H, Hovens MMC, Kaasjager KAH, van Klink RCJ, Kruip MJHA, Loeffen RF, Mairuhu ATA, Middeldorp S, Nijkeuter M, van der Pol LM, Schol-Gelok S, Ten Wolde M, Klok FA, Huisman MV; YEARS study group. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. Lancet. 2017 Jul 15;390(10091):289-297. doi: 10.1016/S0140-6736(17)30885-1. Epub 2017 May 23. Erratum in: Lancet. 2017 Jul 15;390(10091):230. PMID: 28549662.
- Kabrhel C, Van Hylckama Vlieg A, Muzikanski A, Singer A, Fermann GJ, Francis S, Limkakeng A, Chang AM, Giordano N, Parry B. Multicenter Evaluation of the YEARS Criteria in Emergency Department Patients Evaluated for Pulmonary Embolism. Acad Emerg Med. 2018 Sep;25(9):987-994. doi: 10.1111/acem.13417. PMID: 29603819.
- Freund Y, Chauvin A, Jimenez S, et al. Effect of a Diagnostic Strategy Using an Elevated and Age-Adjusted D-Dimer Threshold on Thromboembolic Events in Emergency Department Patients With Suspected Pulmonary Embolism: A Randomized Clinical Trial. JAMA. 2021;326(21):2141–2149. doi:10.1001/jama.2021.20750
- Van der Pol LM, Tromeur C, Bistervels IM, Ni Ainle F, van Bemmel T, Bertoletti L, Couturaud F, van Dooren YPA, Elias A, Faber LM, Hofstee HMA, van der Hulle T, Kruip MJHA, Maignan M, Mairuhu ATA, Middeldorp S, Nijkeuter M, Roy PM, Sanchez O, Schmidt J, Ten Wolde M, Klok FA, Huisman MV; Artemis Study Investigators. Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism. N Engl J Med. 2019 Mar 21;380(12):1139-1149. doi: 10.1056/NEJMoa1813865. PMID: 30893534.
- Freund Y, Chauvin A, Jimenez S, Philippon AL, Curac S, Fémy F, Gorlicki J, Chouihed T, Goulet H, Montassier E, Dumont M, Lozano Polo L, Le Borgne P, Khellaf M, Bouzid D, Raynal PA, Abdessaied N, Laribi S, Guenezan J, Ganansia O, Bloom B, Miró O, Cachanado M, Simon T. Effect of a Diagnostic Strategy Using an Elevated and Age-Adjusted D-Dimer Threshold on Thromboembolic Events in Emergency Department Patients With Suspected Pulmonary Embolism: A Randomized Clinical Trial. JAMA. 2021 Dec 7;326(21):2141-2149. doi: 10.1001/jama.2021.20750. PMID: 34874418; PMCID: PMC8652602.
- Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, Cooley LA, Dean NC, Fine MJ, Flanders SA, Griffin MR, Metersky ML, Musher DM, Restrepo MI, Whitney CG. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67. doi: 10.1164/rccm.201908-1581ST. PMID: 31573350; PMCID: PMC6812437.
- Stiell IG, Clement CM, Aaron SD, Rowe BH, Perry JJ, Brison RJ, Calder LA, Lang E, Borgundvaag B, Forster AJ, Wells GA. Clinical characteristics associated with adverse events in patients with exacerbation of chronic obstructive pulmonary disease: a prospective cohort study. CMAJ. 2014 Apr 1;186(6):E193-204. doi: 10.1503/cmaj.130968. Epub 2014 Feb 18. PMID: 24549125; PMCID: PMC3971051.
- Stiell IG, Perry JJ, Clement CM, Brison RJ, Rowe BH, Aaron SD, McRae AD, Borgundvaag B, Calder LA, Forster AJ, Brinkhurst J, Wells GA. Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department. CMAJ. 2018 Dec 3;190(48):E1406-E1413. doi: 10.1503/cmaj.180232. PMID: 30510045; PMCID: PMC6258211.
- Six AJ, Backus BE, Kelder JC. Chest pain in the emergency room: value of the HEART score. Neth Heart J. 2008 Jun; 16(6): 191-6. PubMed PMID: 18665203; PubMed Central PMCID: PMC2442661.
- Antman EM, Cohen M, et. al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000 Aug 16; 284(7): 835-42.
- Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006 Nov 25; 333(7578): 1091. Epub 2006 Oct 10. PubMed PMID: 17032691; PubMed Central PMCID: PMC1661748.
- Than M, Flaws D, Sanders S, Doust J, Glasziou P, Kline J, Aldous S, Troughton R, Reid C, Parsonage WA, Frampton C, Greenslade JH, Deely JM, Hess E, Sadiq AB, Singleton R, Shopland R, Vercoe L, Woolhouse-Williams M, Ardagh M, Bossuyt P, Bannister L, Cullen L. Development and validation of the Emergency Department Assessment of Chest pain Score and 2 h accelerated diagnostic protocol. Emerg Med Australas. 2014 Feb;26(1):34-44. doi: 10.1111/1742-6723.12164. Epub 2014 Jan 15. PMID: 24428678.
- Than MP, Pickering JW, Aldous SJ, Cullen L, Frampton CM, Peacock WF, Jaffe AS, Goodacre SW, Richards AM, Ardagh MW, Deely JM, Florkowski CM, George P, Hamilton GJ, Jardine DL, Troughton RW, van Wyk P, Young JM, Bannister L, Lord SJ. Effectiveness of EDACS Versus ADAPT Accelerated Diagnostic Pathways for Chest Pain: A Pragmatic Randomized Controlled Trial Embedded Within Practice. Ann Emerg Med. 2016 Jul;68(1):93-102.e1. doi: 10.1016/j.annemergmed.2016.01.001. PMID: 26947800.
- Mark DG, Huang J, Chettipally U, Kene MV, Anderson ML, Hess EP, Ballard DW, Vinson DR, Reed ME; Kaiser Permanente CREST Network Investigators. Performance of Coronary Risk Scores Among Patients With Chest Pain in the Emergency Department. J Am Coll Cardiol. 2018 Feb 13;71(6):606-616. doi: 10.1016/j.jacc.2017.11.064. PMID: 29420956.
- Boyle RSJ, Body R. The Diagnostic Accuracy of the Emergency Department Assessment of Chest Pain (EDACS) Score: A Systematic Review and Meta-analysis. Ann Emerg Med. 2021 Apr;77(4):433-441. doi: 10.1016/j.annemergmed.2020.10.020. Epub 2021 Jan 16. PMID: 33461885.
- Stiell IG, Clement CM, Brison RJ, Rowe BH, Borgundvaag B, Aaron SD, Lang E, Calder LA, Perry JJ, Forster AJ, Wells GA. A risk scoring system to identify emergency department patients with heart failure at high risk for serious adverse events. Acad Emerg Med. 2013 Jan;20(1):17-26. doi: 10.1111/acem.12056. PMID: 23570474.
- Stiell IG, Perry JJ, Clement CM, Brison RJ, Rowe BH, Aaron SD, McRae AD, Borgundvaag B, Calder LA, Forster AJ, Wells GA. Prospective and Explicit Clinical Validation of the Ottawa Heart Failure Risk Scale, With and Without Use of Quantitative NT-proBNP. Acad Emerg Med. 2017 Mar;24(3):316-327. doi: 10.1111/acem.13141. PMID: 27976497.
- Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010 Feb;137(2):263-72. doi: 10.1378/chest.09-1584. Epub 2009 Sep 17. PMID: 19762550.
- CHA₂DS₂-VASc Score for Atrial Fibrillation Stroke Risk. MDCalc.org. Accessed at: https://www.mdcalc.com/calc/801/cha2ds2-vasc-score-atrial-fibrillation-stroke-risk#creator-insights on February 3, 2023.
- Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612. Erratum in: Eur Heart J. 2021 Feb 1;42(5):507. Erratum in: Eur Heart J. 2021 Feb 1;42(5):546-547. Erratum in: Eur Heart J. 2021 Oct 21;42(40):4194. PMID: 32860505.
- January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, Ellinor PT, Ezekowitz MD, Field ME, Furie KL, Heidenreich PA, Murray KT, Shea JB, Tracy CM, Yancy CW. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation. 2019 Jul 9;140(2):e125-e151. doi: 10.1161/CIR.0000000000000665. Epub 2019 Jan 28. Erratum in: Circulation. 2019 Aug 6;140(6):e285. PMID: 30686041.
- Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010 Nov;138(5):1093-100. doi: 10.1378/chest.10-0134. Epub 2010 Mar 18. PMID: 20299623.
- Lip GY, Frison L, Halperin JL, Lane DA. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. J Am Coll Cardiol. 2011 Jan 11;57(2):173-80. doi: 10.1016/j.jacc.2010.09.024. Epub 2010 Nov 24. PMID: 21111555.
- Zhu W, He W, Guo L, Wang X, Hong K. The HAS-BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis. Clin Cardiol. 2015 Sep;38(9):555-61. doi: 10.1002/clc.22435. PMID: 26418409; PMCID: PMC6490831.
- Blatchford O, Murray WR, Blatchford M. A risk score to predict need for treatment for uppergastrointestinal haemorrhage. Lancet. 2000 Oct 14; 356(9238): 1318-21.
- Stanley AJ, Ashley D, Dalton HR, Mowat C, Gaya, GR, et al. Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation. Lancet. 2009 Jan; 373(9657): 42–47.
- Stanley AJ, Laine L, Dalton HR, Ngu JH, Schultz M, Abazi R, Zakko L, Thornton S, Wilkinson K, Khor CJ, Murray IA, Laursen SB; International Gastrointestinal Bleeding Consortium. Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: international multicentre prospective study. BMJ. 2017 Jan 4;356:i6432. doi: 10.1136/bmj.i6432. PMID: 28053181; PMCID: PMC5217768.
- Oakland K, Jairath V, Uberoi R, Guy R, Ayaru L, Mortensen N, Murphy MF, Collins GS. Derivation and validation of a novel risk score for safe discharge after acute lower gastrointestinal bleeding: a modelling study. Lancet Gastroenterol Hepatol. 2017 Sep;2(9):635-643. doi: 10.1016/S2468-1253(17)30150-4. Epub 2017 Jun 23. PMID: 28651935.
- Oakland K, Kothiwale S, Forehand T, Jackson E, Bucknall C, Sey MSL, Singh S, Jairath V, Perlin J. External Validation of the Oakland Score to Assess Safe Hospital Discharge Among Adult Patients With Acute Lower Gastrointestinal Bleeding in the US. JAMA Netw Open. 2020 Jul 1;3(7):e209630. doi: 10.1001/jamanetworkopen.2020.9630. PMID: 32633766; PMCID: PMC7341175.
- Alvarado A. A practical score for the early diagnosis of acute appendicitis. Ann Emerg Med. 1986 May;15(5):557-64. doi: 10.1016/s0196-0644(86)80993-3. PMID: 3963537.
- Coleman JJ, Carr BW, Rogers T, Field MS, Zarzaur BL, Savage SA, Hammer PM, Brewer BL, Feliciano DV, Rozycki GS. The Alvarado score should be used to reduce emergency department length of stay and radiation exposure in select patients with abdominal pain. J Trauma Acute Care Surg. 2018 Jun;84(6):946-950. doi: 10.1097/TA.0000000000001885. PMID: 29521805.
- Pogorelić Z, Rak S, Mrklić I, Jurić I. Prospective validation of Alvarado score and Pediatric Appendicitis Score for the diagnosis of acute appendicitis in children. Pediatr Emerg Care. 2015 Mar;31(3):164-8. doi: 10.1097/PEC.0000000000000375. PMID: 25706925.
- Kharbanda AB, Vazquez-Benitez G, Ballard DW, Vinson DR, Chettipally UK, Kene MV, Dehmer SP, Bachur RG, Dayan PS, Kuppermann N, O’Connor PJ, Kharbanda EO. Development and Validation of a Novel Pediatric Appendicitis Risk Calculator (pARC). Pediatrics. 2018 Apr;141(4):e20172699. doi: 10.1542/peds.2017-2699. Epub 2018 Mar 13. PMID: 29535251; PMCID: PMC5869337.
- Cotton DM, Vinson DR, Vazquez-Benitez G, Margaret Warton E, Reed ME, Chettipally UK, Kene MV, Lin JS, Mark DG, Sax DR, McLachlan ID, Rauchwerger AS, Simon LE, Kharbanda AB, Kharbanda EO, Ballard DW; Clinical Research on Emergency Services and Treatments (CREST) Network. Validation of the Pediatric Appendicitis Risk Calculator (pARC) in a Community Emergency Department Setting. Ann Emerg Med. 2019 Oct;74(4):471-480. doi: 10.1016/j.annemergmed.2019.04.023. Epub 2019 Jun 19. PMID: 31229394; PMCID: PMC8364751.
- Moore CL, Bomann S, Daniels B, Luty S, Molinaro A, Singh D, Gross CP. Derivation and validation of a clinical prediction rule for uncomplicated ureteral stone–the STONE score: retrospective and prospective observational cohort studies. BMJ. 2014 Mar 26;348:g2191. doi: 10.1136/bmj.g2191. PMID: 24671981; PMCID: PMC3966515.
- Hernandez N, Song Y, Noble VE, Eisner BH. Predicting ureteral stones in emergency department patients with flank pain: an external validation of the STONE score. World J Urol. 2016 Oct;34(10):1443-6. doi: 10.1007/s00345-016-1760-3. Epub 2016 Jan 16. PMID: 26780732.
- Wang RC, Rodriguez RM, Moghadassi M, Noble V, Bailitz J, Mallin M, Corbo J, Kang TL, Chu P, Shiboski S, Smith-Bindman R. External Validation of the STONE Score, a Clinical Prediction Rule for Ureteral Stone: An Observational Multi-institutional Study. Ann Emerg Med. 2016 Apr;67(4):423-432.e2. doi: 10.1016/j.annemergmed.2015.08.019. Epub 2015 Oct 3. PMID: 26440490; PMCID: PMC4808407.
- Daniels B, Gross CP, Molinaro A, Singh D, Luty S, Jessey R, Moore CL. STONE PLUS: Evaluation of Emergency Department Patients With Suspected Renal Colic, Using a Clinical Prediction Tool Combined With Point-of-Care Limited Ultrasonography. Ann Emerg Med. 2016 Apr;67(4):439-48. doi: 10.1016/j.annemergmed.2015.10.020. Epub 2015 Dec 31. PMID: 26747219; PMCID: PMC5074842.
- Perry JJ, Stiell IG, Sivilotti MA, et al. Clinical decision rules to rule out subarachnoid hemorrhage for acute headache. JAMA. 2013; 310(12): 1248-1255. doi:10.1001/jama.2013.278018.
- Bellolio MF, Hess EP, Gilani W, VanDyck TJ, Ostby SA, et al. External validation of the Ottawa subarachnoid hemorrhage clinical decision rule in patients with acute headache. Am J Emerg Med. 2015 Feb; 33(2): 244-9. doi: 10.1016/j.ajem.2014.11.049. Epub 2014 Dec 3.
- Perry JJ, Sharma M, Sivilotti ML, Sutherland J, Worster A, Émond M, Stotts G, Jin AY, Oczkowski WJ, Sahlas DJ, Murray HE, MacKey A, Verreault S, Wells GA, Stiell IG. A prospective cohort study of patients with transient ischemic attack to identify high-risk clinical characteristics. Stroke. 2014 Jan;45(1):92-100. doi: 10.1161/STROKEAHA.113.003085. Epub 2013 Nov 21. PMID: 24262323.
- Perry JJ, Sivilotti MLA, Émond M, Stiell IG, Stotts G, Lee J, Worster A, Morris J, Cheung KW, Jin AY, Oczkowski WJ, Sahlas DJ, Murray HE, Mackey A, Verreault S, Camden MC, Yip S, Teal P, Gladstone DJ, Boulos MI, Chagnon N, Shouldice E, Atzema C, Slaoui T, Teitlebaum J, Abdulaziz K, Nemnom MJ, Wells GA, Sharma M. Prospective validation of Canadian TIA Score and comparison with ABCD2 and ABCD2i for subsequent stroke risk after transient ischaemic attack: multicentre prospective cohort study. BMJ. 2021 Feb 4;372:n49. doi: 10.1136/bmj.n49. Erratum in: BMJ. 2021 Feb 18;372:n453. PMID: 33541890; PMCID: PMC7859838.
- Quinn JV, Stiell IG, McDermott DA, Sellers KL, Kohn MA, Wells GA. Derivation of the San Francisco Syncope Rule to predict patients with short-term serious outcomes. Ann Emerg Med. 2004 Feb; 43(2): 224-32.
- Quinn J, McDermott D, Stiell I, Kohn M, Wells G. Prospective validation of the San Francisco Syncope Rule to predict patients with serious outcomes. Ann Emerg Med. 2006 May; 47(5): 448-54. Epub 2006 Jan 18. PubMed PMID: 16631985.
- Birnbaum A, Esses D, Bijur P, Wollowitz A, Gallagher EJ. Failure to validate the San Francisco Syncope Rule in an independent emergency department population. Ann Emerg Med. 2008 Aug; 52(2): 151-9. Epub 2008 Feb 20. PubMed PMID: 18282636.
- Snead GR, Wilbur LG. Can the San Francisco Syncope Rule predict short-term serious outcomes in patients presenting with syncope? Ann Emerg Med. 2013;62: 267-268.
- Saccilotto RT, Nickel CH, Bucher HC, Steyerberg EW, Bingisser R, Koller MT. San Francisco Syncope Rule to predict short-term serious outcomes: a systematic review. CMAJ. 2011 Oct 18; 183(15): e1116–e1126. doi: 1503/cmaj.101326
- Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. The diagnosis of strep throat in adults in the emergency room. Med Decis Making. 1981; 1(3): 239-46.
- McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA.2004; 291(13): 1587-1595. doi:10.1001/jama.291.13.1587.
- Fine AM, Nizet, V, Mandl KD. Large-scale validation of the Centor and McIsaac Scores to predict group A streptococcal pharyngitis. Arch Intern Med. 2012 Jun 11; 172(11): 847–852. doi: 1001/archinternmed.2012.950.
- Pichichero ME. Treatment and prevention of streptococcal tonsillopharyngitis. UpToDate.com. Available online at: http://www.uptodate.com/contents/treatment-and-prevention-of-streptococcal-tonsillopharyngitis?source=machineLearning&search=centor+criteria&selectedTitle=1~2§ionRank=1&anchor=H9#H3. Accessed Dec. 2, 2015.
- Wald ER, Green MD, Schwartz B, Barbadora K. A streptococcal score card revisited. Pediatr Emerg Care. 1998; 14(2): 109.
- Ebell MH, Smith MA, Barry HC, et al. The rational clinical examination: does this patient have strep throat? JAMA 2000; 284: 2912– 2918.
Additional Online Resources
- Emergency Medicine Cases podcast: Clinical Decision Rules and Risk Scales. This hour-long podcast discusses the overall use of CDRs and Risk Scales and how they are developed and used, with a discussion with Dr. Ian Stiell, the “father of clinical decision rules” from Ottawa, Canada. http://emergencymedicinecases.com/episode-56-stiell-sessions-clinical-decision-rules-risk-scales/
- Agile MD app. You can download the AgileMD app for free and then download the EM Cases Summaries for free. Within EM Cases Summaries is a link to the “Ottawa CDRs and Risk Scales.” This includes shortcut to the Ottawa Ankle and Knee Rules, the Canadian C-spine and CT Head Rules, and the Ottawa COPD, Heart Failure, and TIA Risk Scores.
- EmDOCS.net is a FOAMed initiative with a series of posts on Clinical Decision Rules.
- There are numerous EM blogs and podcasts that provide education for EM trainees and physicians. Many are listed here: https://www.emra.org/about-emra/publications/recommended-blogs-and-podcasts/. The podcast EMCrit and EM:RAP in particular have episodes on Clinical Decision Rules.
Reviewed and Edited By
Arif Alper Cevik, MD, FEMAT, FIFEM
Prof Cevik is an Emergency Medicine academician at United Arab Emirates University, interested in international emergency medicine, emergency medicine education, medical education, point of care ultrasound and trauma. He is the founder and director of the International Emergency Medicine Education Project – iem-student.org, vice-chair of the International Federation for Emergency Medicine (IFEM) core curriculum and education committee and board member of the Asian Society for Emergency Medicine and Emirati Board of Emergency Medicine.
Sharing is caring
- Click to share on X (Opens in new window) X
- Click to share on Reddit (Opens in new window) Reddit
- Click to share on LinkedIn (Opens in new window) LinkedIn
- Click to share on Facebook (Opens in new window) Facebook
- Click to share on Tumblr (Opens in new window) Tumblr
- Click to share on Pinterest (Opens in new window) Pinterest
- Click to share on WhatsApp (Opens in new window) WhatsApp
- Click to email a link to a friend (Opens in new window) Email
- Click to print (Opens in new window) Print









